Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-03-09
1995-01-10
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514422, 5142352, 514340, 514 43, 548455, 548430, 546198, 544142, 544143, 536 286, C07D40114, C07D40314, C07D41314, A61K 3140, A61K 31445, A61K 31535
Patent
active
053807464
ABSTRACT:
The present invention provides bis-(1H-indol-3-yl)maleinimide derivatives and the pharmacologically acceptable salts thereof, processes for the preparation of these compounds, and pharmaceutical compositions containing them for the treatment of heart and blood vessel diseases, such as thromboses, arteriosclerosis, hypertension, of inflammatory processes, allergies, cancer, and certain degenerative damages of the central nervous system, as well as of diseases of the immune system and viral diseases.
REFERENCES:
patent: 4912107 (1990-03-01), Kleinschroth et al.
Tetrahedron Letters, 28(38):4441-4444 (1987), J. Bergman et al., "Coupling of Indoleacetic Acid Trianion . . .".
Febs Lett., 259(1): 61-63 (1989), P. D. Davis et al., "Potent Selective Inhibitors of Protein Kinase-C".
Barth Hubert
Betche Hans-Jurgen
Hartenstein Johannes
Osswald Hartmut
Reck Reinhard
Anderson Elizabeth M.
Goedecke Aktiengesellschaft
Springer David B.
LandOfFree
Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-850899